ProShares Ultra NASDAQ Biotechnology
19 hedge funds and large institutions have $3.4M invested in ProShares Ultra NASDAQ Biotechnology in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
19
Holders Change
-5
Holders Change %
-20.83%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
4
Closed
6
Calls
$2.24M
Puts
$2.27M
Net Calls
-$30K
Net Calls Change
+$782K